Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI
- 1 August 2011
- journal article
- research article
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 7 (4) , 437-441
- https://doi.org/10.4244/eijv7i4a72
Abstract
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Keywords
This publication has 13 references indexed in Scilit:
- A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?European Heart Journal, 2008
- Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registryEuropean Heart Journal, 2006
- Trends in Management and Outcomes of Patients With Acute Myocardial Infarction Complicated by Cardiogenic ShockJAMA, 2005
- Recognition and Treatment of Cardiogenic ShockSeminars in Respiratory and Critical Care Medicine, 2004
- Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI)Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)Published by Oxford University Press (OUP) ,2004
- Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: The benchmark registryJournal of the American College of Cardiology, 2003
- The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2American Heart Journal, 2001
- Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic ShockNew England Journal of Medicine, 1999
- A Prospective, Randomized Evaluation of Prophylactic Intraaortic Balloon Counterpulsation in High Risk Patients With Acute Myocardial Infarction Treated With Primary Angioplasty fn1fn1Funding for this study was provided in part by unrestricted grants from Advanced Cardiovascular Systems, Inc., Santa Clara, California; Mallinkrodt Medical, Inc., Saint Louis, Missouri; Datascope Corporation, Montvale, New Jersey; St. Jude Medical, Chelmsford, Massachusetts; and Siemens Corporation, Iselin, New Jersey.Journal of the American College of Cardiology, 1997
- Counterpulsation: Historical Background, Technical Improvements, Hemodynamic and Metabolic EffectsCardiology, 1994